Cases & Deals

  • Home
  • Practices
  • AquaBounty completes $10 million sale of Common Shares to Intrexon

Share

AquaBounty completes $10 million sale of Common Shares to Intrexon

March 2014

Client(s) AquaBounty Technologies

Jones Day represented AquaBounty Technologies, a biotechnology company focused on enhancing productivity in the aquaculture market, in its $10 million sale of new Common Shares to Intrexon Corporation, a biotechnology company operating in the synthetic biology field.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.